Europe’s clinical landscape is fragmented and built around hospitals, leaving eligible patients disconnected, studies slow to start and sites overburdened.
iduneo connects hospitals into a clinical trial network and runs trials across it — planning, contracting, enrolling, and conducting as one process.
One network, three sides: sponsors get trials that recruit, clinics get trials that fit, patients get access they would not otherwise have.
Point solutions leave the sponsor as the integrator. iduneo runs the process end-to-end — planning, contracting, enrolling, and conducting oncology trials across a connected hospital network, built on clinical documentation as it exists today, not historical registry averages.
Where a trial will recruit — not where it recruited before.
We model where a trial will recruit well, using live clinical documentation from connected sites — not historical registry averages. A trajectory, not a static feasibility snapshot.
The right clinics, under contract, fast.
We help get the right clinics contracted and trial-ready — clearing the administrative and legal work that normally sits between a sponsor and a running site.
One site. The whole network's patients.
AI-supported identification and pre-screening, integrated into clinical workflows on premise inside each hospital — and referral across the network beyond it. Partner institutions identify eligible patients and refer them to the right site.
Not data points. People.
Once a trial is running, we handle pre-qualification, referral logistics, and coordination — and capture the reasons behind treatment switches, declines, and outcomes: the clinical context that sits outside the study's own case report form.
We wanted one partner to own planning and contracting — and be accountable for delivering on what they predicted.
Pharmaceutical Partner · Clinical Operations
iduneo gives your clinic access to oncology trials that match your actual patient population — and makes running them easier, without adding headcount or infrastructure.
We help acquire suitable trials, support contracting and site activation, and prepare source data. The operational work that normally stands between your clinic and a running trial, taken off your plate before recruitment even starts.
iduneo gives your clinic access to oncology trials that match your actual patient population — not whatever happens to be available. We bring you international research that might otherwise stay out of reach.
Connected sites refer eligible patients to one another. Your clinic can enrol patients it would never have seen, and refer patients for whom you cannot offer a local trial option today.
Once a trial is running, iduneo supports pre-qualification, referral logistics, and coordination — so you can manage more patients with less administrative load. Your time stays where it matters: with patients and clinical decisions.
Talk to our team →We want to win and run more clinical trials — without adding headcount or infrastructure. iduneo lets us use the capacity we already have.
Oncology Department Head · Partner Clinic
Clinical trials can give access to new therapies — often earlier than standard care. Many people don't know which trials might suit them, or how to take the first step.
Our patient service helps you understand whether a trial might be right for you, step by step, with personal support. Free and confidential.
Within 48 hours I had three concrete trial options.
Three weeks later, I was in study treatment.Patient · OnkoPlus DACH
iduneo was founded in 2024 to run what Europe does not have: a connected clinical trial network in oncology. The integrated model works in the US. Europe's fragmentation means no one has been able to operate it here.
Our model is asset-light. We connect hospitals that already treat these patients rather than owning sites, so the network grows without acquiring infrastructure. Our focus is narrow by design: clinical phase delivery for oncology, in Europe.
Whether you represent a pharmaceutical company, a treatment center, or a research institution — we would like to hear from you.